# Aclid, Inc.

Canonical: https://abierto.us/vendors/aclid-inc-mc9nky6nrrq5

- UEI: MC9NKY6NRRQ5
- CAGE: 9BWZ1
- Location: Staten Island, NY
- Awards in window: 1 (1 transactions), $167,338 obligated, September 12, 2024 to September 12, 2024

## Awarding agencies

- Defense Threat Reduction Agency: 1 awards, $167,338

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $167,338

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- HDTRA124P0047 (purchase order): $167,338, Defense Threat Reduction Agency. Sibr Phase I - Aclid Nucleotide Sequencing Research and Development Study. https://www.usaspending.gov/award/CONT_AWD_HDTRA124P0047_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/aclid-inc-mc9nky6nrrq5.